Eupraxia Pharmaceuticals (EPRX) Interest & Investment Income (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Interest & Investment Income of $1.39 million in the quarter ended Jun 30, 2026, up 443.8% from $255,958 a year earlier and up 29.6% from the prior quarter.
Eupraxia Pharmaceuticals (EPRX) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a TTM basis, Eupraxia Pharmaceuticals' Interest & Investment Income came in at $3.31 million as of Jun 30, 2026, up 204.6% year-over-year; for the year ended Dec 31, 2025, it was $1.41 million, up 21.8% from the prior year.
- Annual Interest & Investment Income has increased for three straight years, with a three-year compound annual growth rate of 48.4% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Interest & Investment Income came in at $1.16 million in the year ended Dec 31, 2024 (+34.4%), $862,969 in the year ended Dec 31, 2023 (+99.9%) and $431,799 in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Interest & Investment Income in data going back to the quarter ended Mar 31, 2023.
- On a year-over-year basis, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 108.7% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 443.8% in the quarter ended Jun 30, 2026, against a decline of 40.8% in the quarter ended Sep 30, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.07 million (quarter ended Mar 31, 2026), $666,921 (quarter ended Dec 31, 2025) and $180,185 (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 289.28 Mn | 287.68 Mn | - | 1.39 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 666,921.00 |
| Sep 30, 2025 | 180,185.00 |
| Jun 30, 2025 | 255,958.00 |
| Mar 31, 2025 | 309,452.00 |
| Dec 31, 2024 | 218,006.00 |
| Sep 30, 2024 | 304,342.00 |
| Jun 30, 2024 | 401,226.00 |
| Mar 31, 2024 | 236,369.00 |
| Dec 31, 2023 | 353,790.00 |
| Sep 30, 2023 | 193,875.00 |
| Jun 30, 2023 | 152,271.00 |
| Mar 31, 2023 | 163,033.00 |
Eupraxia Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();